Cretin, Benjamin http://orcid.org/0000-0001-9302-755X
Article History
Accepted: 18 November 2020
First Online: 14 December 2020
Declarations
:
: No funding was received for the preparation of this article.
: Benjamin Cretin reports fees and honorarium from UCB-Pharma, Eisai-Pharma, and Advicenne-Pharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BC designed and conceptualized study, analyzed the data, drafted the manuscript for intellectual content, and read and approved the final version of the manuscript.